Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 129   

Articles published

NVO 44.29 -0.06 (-0.14%)
price chart
FDA Expected To Approve Two More Weight Loss Drugs
On the same day, the regulator has invited its advisors to come together and discuss Novo Nordisk A/S' (ADR) (NVO) intravenous injection to combat obesity.
Related articles »  
Trader's Buzzers � Liberty Interactive (NASDAQ:LVNTA), Novo Nordisk A/S ...
Novo Nordisk A/S (ADR) (NYSE:NVO) gained 2.38% and ended at $44.33. The total traded volume was 1.75 million shares and market capitalization arrived at $91.39 billion.
Related articles »  
Big Movers: Coach, Inc. (NYSE:COH), Novo Nordisk A/S (ADR)(NYSE:NVO ...
Lakeway, NY - (MARKET NEWS CALL) - 10/28/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Novo Nordisk A/S Rating Reiterated by Zacks (NVO)
Novo Nordisk A/S (ADR) logo Novo Nordisk A/S (NYSE:NVO)'s stock had its �neutral� rating reissued by Zacks in a research report issued on Monday.
Related articles »  
Novo Nordisk A/S: Stock split information
The trading unit of the Novo Nordisk B shares listed on the stock exchange in Copenhagen will be changed from DKK 1 to DKK 0.20.
Related articles »  
Hedge Funds Are Selling Novo Nordisk A/S (ADR) (NYSE:NVO) - Forest ...
Is Novo Nordisk A/S (ADR) (NYSE:NVO) ready to raly soon? Money managers are turning less bullish. The number of long hedge fund positions retreated by 1 lately.
Related articles »  
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co ...
Doctors like to see patients get their A1c levels below 7%, but the portion of the patients who reached the target was higher in the group taking Novo Nordisk A/S (ADR) (NYSE:NVO)'s injected insulin Novolog than the Afrezza group. The proportion ...
Related articles »  
Technology Stocks Intraday Alert - Novo Nordisk A/S (ADR)(NYSE:NVO ...
Stamford, Connecticut - November 18, 2014- (Techsonian) ��OTC Stock Picks newsletter alerts the market with picks that Wall Street stock traders have ignored or haven't found out about yet.
Novo Nordisk A/S (ADR) (NVO): Insiders Aren't Crazy About It
Novo Nordisk A/S (ADR) (NYSE:NVO) was in 13 hedge funds' portfolio at the end of the first quarter of 2013. NVO shareholders have witnessed a decrease in support from the world's most elite money managers lately.
US Pharma Sales Growth Rebounds
Of these, AbbVie Inc. (ABBV), Novo Nordisk A/S ADR (NVO), and Bayer AG ADR (BAYRY) are expected to see their revenues compound at the highest annual growth rates of 9.6%, 8.9%, and 6.1%, respectively, over the next three years starting from August ...